Delivery Order SPE2DB20D1100-SPE2DB25FB8P8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (2024-25, 6-month to 4-year formulation, 0.9ml) valued at $1,570.70, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of vaccine product to support federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9ML) with a firm fixed price structure. The contract, awarded on July 16, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. Performance will take place at the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.15 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9mL) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's broader contract vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,570.70 for Pfizer COVID-19 vaccines (2024-25 formulation, 0.9ml) with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order through its...
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (2024-25 formulation, 0.9 mL, Emergency Use Authorization) with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen...
- The U.S. Defense Logistics Agency awarded a $3,141.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9 mL) with an ultimate completion date of August 12, 2025. This non-set-aside competitive award was issued on July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- This delivery order, valued at $1,570.70, was awarded on July 14, 2025, to AmerisourceBergen Drug Corp for the supply of Pfizer COVID-19 vaccine (2024-25 formulation, 0.9mL) under an Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,269.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Pfizer COVID-19 vaccine doses with a delivery period from June 2023 to February 2024. This contract was not set aside for any particular business type. Amerisourcebergen Drug Corp is the prime contractor and is responsible for delivering the 0.9 mL vaccine doses to the designated location in...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pfizer COVID-19 vaccine (2024-25 formulation, 0.9mL) under a firm fixed-price contract with a ceiling value of $1,570.70. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,135.77, is for the procurement of Pfizer COVID-19 vaccines with a 0.9mL dosage for the 2024-2025 period, under a Firm Fixed Price contract. The award has an ultimate completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB8P8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (0.9 mL) under contract 4567983925. This firm fixed-price delivery order, issued on April 21, 2025, with an ultimate completion date of May 12, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability to fulfill federal medical procurement requirements through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 4/21/25 |